Morris, Michael J. http://orcid.org/0000-0002-9454-0096
Corey, Eva http://orcid.org/0000-0002-9244-3807
Guise, Theresa A.
Gulley, James L. http://orcid.org/0000-0002-6569-2912
Kevin Kelly, William
Quinn, David I.
Scholz, Arne
Sgouros, George http://orcid.org/0000-0002-4553-2866
Article History
Accepted: 15 October 2019
First Online: 11 November 2019
Competing interests
: M.J.M. declares participation as a compensated member of advisory boards for Advanced Accelerated Applications, an uncompensated member of advisory boards for Bayer, Endocyte and Progenics and research funding (for institute) from Bayer, Endocyte, Progenics and Corcept. E.C. and T.A.G. declare participation as compensated members of a round-table meeting from Bayer and research funding (for institute) from Bayer. W.K.K. declares clinical trial support from Bayer. D.I.Q. declares participation as a compensated member of advisory boards from Astellas, Bayer, Janssen, Genzyme, Dendreon and AstraZeneca. A.S. is a full-time employee of Bayer. G.S. is a consultant for Bayer and holds ownership in a start-up company that Bayer has used for imaging and dosimetry analyses. J.L.G declares no competing interests.